Mode
Text Size
Log in / Sign up
Phase 4 Completed N=37 Randomized Triple-blind Treatment

Optimizing Surgical Conditions During Laparoscopic Herniotomy With Deep Neuromuscular Blockade

Laparoscopic Herniotomy
Source: ClinicalTrials.gov NCT02247466 ↗
Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcomePrimary: Improvement of Surgical Workspace — 0; 1; 0; 0 Participants
◆ Published Evidence
Emerging
18citations · ~2 / year
Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study.
European journal of anaesthesiology · 2018 · Likely link

Summary

The purpose of this study is to investigate surgical work space and surgical conditions in patients scheduled for laparoscopic umbilical, -linea alba and incisional herniotomy. The patients will act as their own control with evaluation of surgical work space and surgical conditions during both deep NMB and no NMB.

Linked Publications (2)

  • Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study.
    European journal of anaesthesiology · 2018 · 18 citations · Likely link
  • Neuromuscular blockade during laparoscopic ventral herniotomy: protocol for a randomised controlled trial.
    Danish medical journal · 2015 · 5 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Improvement of Surgical Workspace
0; 1; 0; 0; 0; 4
SECONDARY
Surgical Conditions While Suturing
0; 0; 0; 0; 0; 2
SECONDARY
Operating Time
61; 64
SECONDARY
Suturing Time
10; 9
SECONDARY
Contractions
1; 0
SECONDARY
Insufflator Alarms
0; 0
SECONDARY
Continuous Abdominal Contractions
0; 0
SECONDARY
Recurrences of Hernias

Eligibility Criteria

Inclusion Criteria

  • Patients > 18 years old
  • Elective laparoscopic umbilical herniotomy, incisional herniotomy and linea alba - herniotomy
  • Can read and understand Danish
  • Informed consent

Exclusion Criteria

  • Known allergy to sugammadex, rocuronium or mivacurium
  • Known homozygous variants in the butyrylcholinesterase gene
  • Severe renal disease, defined by S-creatinine> 0.200 mmol/L, GFR < 30ml/min or hemodialysis)
  • Neuromuscular disease that may interfere with neuromuscular data
  • Lactating or pregnant (Women of child bearing potential must take a urine pregnancy test at the day of the operation. The test will be provided by the hospital staff).
  • Indication for rapid sequence induction
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02247466) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search